SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001920179-23-000005
Filing Date
2023-01-11
Accepted
2023-01-11 16:09:21
Documents
1
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 10218
  Complete submission text file 0001920179-23-000005.txt   11833
Mailing Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR
Business Address MAXIM 1 2 PARKLANDS WAY HOLYTOWN X0 ML1 4WR 01414337557
TC BioPharm (Holdings) plc (Issuer) CIK: 0001872812 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O RENAISSANCE CAPITAL PARTNERS LTD 42 SHAD THAMES LONDON X0 SE1 2YD
Business Address
Randall Mark Edward (Reporting) CIK: 0001916323 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-41231 | Film No.: 23523682